Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution

Ana Marco-Rico,1,2 Pascual Marco-Vera2,3 1Hemostasis and Thrombosis Department, Hematology Service, University General Hospital Dr. Balmis, Alicante, Spain; 2Biomedical Research Institute (ISABIAL), Alicante, Spain; 3Clinical Medicine Department, Miguel Hernández University, Alicante, SpainCorrespon...

Full description

Bibliographic Details
Main Authors: Marco-Rico A, Marco-Vera P
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Journal of Blood Medicine
Subjects:
Online Access:https://www.dovepress.com/antithrombin-deficiency-and-thrombosis-a-wide-clinical-scenario-report-peer-reviewed-fulltext-article-JBM
_version_ 1797694050391818240
author Marco-Rico A
Marco-Vera P
author_facet Marco-Rico A
Marco-Vera P
author_sort Marco-Rico A
collection DOAJ
description Ana Marco-Rico,1,2 Pascual Marco-Vera2,3 1Hemostasis and Thrombosis Department, Hematology Service, University General Hospital Dr. Balmis, Alicante, Spain; 2Biomedical Research Institute (ISABIAL), Alicante, Spain; 3Clinical Medicine Department, Miguel Hernández University, Alicante, SpainCorrespondence: Ana Marco-Rico, Hemostasis and Thrombosis Department, Hematology Service, University General Hospital Dr. Balmis, Pintor Baeza Avenue, 12, Alicante, 03010, Spain, Tel +34 965913863, Fax +34 965913869, Email marco_anaric@gva.esAbstract: Congenital antithrombin (AT) deficiency represents the form of thrombophilia with the highest thrombotic risk. It is characterized by a heterogeneous clinical presentation, depending mostly on the family history of thrombosis and type of genetic mutation. Inherited AT deficiency promotes idiopathic thrombosis at an early age (even in the pediatric population) and at atypical sites. Therefore, a positive family background necessitates ruling out this high-risk thrombophilia at a young age. Studying first-degree relatives, even if they are asymptomatic, is essential to establish thromboprophylaxis and a proper therapeutic approach in case of thrombosis. Patients with congenital AT deficiency require indefinite anticoagulation owing to the high thrombotic recurrence rate. Here, we present four unrelated cases reported in our institution who were diagnosed with hereditary AT deficiency, with a contrasting clinical evolution.Keywords: hereditary antithrombin deficiency, thrombosis, anticoagulation, heparin resistance, SERPINC1 gene mutation
first_indexed 2024-03-12T02:52:23Z
format Article
id doaj.art-97ccadc5b4fe4156b87e093f48130b3f
institution Directory Open Access Journal
issn 1179-2736
language English
last_indexed 2024-03-12T02:52:23Z
publishDate 2023-09-01
publisher Dove Medical Press
record_format Article
series Journal of Blood Medicine
spelling doaj.art-97ccadc5b4fe4156b87e093f48130b3f2023-09-03T19:02:41ZengDove Medical PressJournal of Blood Medicine1179-27362023-09-01Volume 1449950686366Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single InstitutionMarco-Rico AMarco-Vera PAna Marco-Rico,1,2 Pascual Marco-Vera2,3 1Hemostasis and Thrombosis Department, Hematology Service, University General Hospital Dr. Balmis, Alicante, Spain; 2Biomedical Research Institute (ISABIAL), Alicante, Spain; 3Clinical Medicine Department, Miguel Hernández University, Alicante, SpainCorrespondence: Ana Marco-Rico, Hemostasis and Thrombosis Department, Hematology Service, University General Hospital Dr. Balmis, Pintor Baeza Avenue, 12, Alicante, 03010, Spain, Tel +34 965913863, Fax +34 965913869, Email marco_anaric@gva.esAbstract: Congenital antithrombin (AT) deficiency represents the form of thrombophilia with the highest thrombotic risk. It is characterized by a heterogeneous clinical presentation, depending mostly on the family history of thrombosis and type of genetic mutation. Inherited AT deficiency promotes idiopathic thrombosis at an early age (even in the pediatric population) and at atypical sites. Therefore, a positive family background necessitates ruling out this high-risk thrombophilia at a young age. Studying first-degree relatives, even if they are asymptomatic, is essential to establish thromboprophylaxis and a proper therapeutic approach in case of thrombosis. Patients with congenital AT deficiency require indefinite anticoagulation owing to the high thrombotic recurrence rate. Here, we present four unrelated cases reported in our institution who were diagnosed with hereditary AT deficiency, with a contrasting clinical evolution.Keywords: hereditary antithrombin deficiency, thrombosis, anticoagulation, heparin resistance, SERPINC1 gene mutationhttps://www.dovepress.com/antithrombin-deficiency-and-thrombosis-a-wide-clinical-scenario-report-peer-reviewed-fulltext-article-JBMhereditary antithrombin deficiencythrombosisanticoagulationheparin resistanceserpinc1 gene mutation
spellingShingle Marco-Rico A
Marco-Vera P
Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
Journal of Blood Medicine
hereditary antithrombin deficiency
thrombosis
anticoagulation
heparin resistance
serpinc1 gene mutation
title Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
title_full Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
title_fullStr Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
title_full_unstemmed Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
title_short Antithrombin Deficiency and Thrombosis: A Wide Clinical Scenario Reported in a Single Institution
title_sort antithrombin deficiency and thrombosis a wide clinical scenario reported in a single institution
topic hereditary antithrombin deficiency
thrombosis
anticoagulation
heparin resistance
serpinc1 gene mutation
url https://www.dovepress.com/antithrombin-deficiency-and-thrombosis-a-wide-clinical-scenario-report-peer-reviewed-fulltext-article-JBM
work_keys_str_mv AT marcoricoa antithrombindeficiencyandthrombosisawideclinicalscenarioreportedinasingleinstitution
AT marcoverap antithrombindeficiencyandthrombosisawideclinicalscenarioreportedinasingleinstitution